Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone.
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
To test the hypothesis that bone metastasis is related to the rate of bone remodeling, we have examined the effect of enhanced bone resorption on the growth of spontaneously metastatic Walker 256 (W256) cancer cells. Bone resorption was stimulated in male Fischer rats by injecting Rice H-500 Leydig tumor cells subcutaneously. The resorptive response of the skeleton was confirmed in a pilot study by evaluating parameters of bone morphometry after 4, 7 and 10 days of tumor burden. The distal femoral epiphyses had 35 +/- 10% more osteoclast surface, 83 +/- 11% less osteoblast surface, and 46 +/- 5% less trabecular bone after 10 days of tumor burden, compared to non-tumor-bearing controls. To evaluate the effect of Leydig tumor-induced bone resorption on the growth response of W256 cells, 20 rats were injected intramuscularly with 2 x 10(7) W256 cells, and 20 rats were vehicle-injected. Two days later, 10 rats from each group were injected subcutaneously with Leydig tumor cells. Twelve days after W256/vehicle injection, rats were injected with [3H]thymidine, killed 2 h later, and their femurs, liver, lungs and kidneys were processed for histology. In rats injected with Leydig tumor cells only, enhanced bone resorption was confirmed by a 40 +/- 4% increase in serum calcium concentration, a 48 +/- 8% decrease in trabecular bone content, and a 72 +/- 15% decrease in osteoblast surface, compared with non-tumor-bearing rats. Metastatic W256 cells adjacent to trabecular bone in Leydig tumor-bearing rats had a 56 +/- 18% greater relative [3H]thymidine labeling index (TdR) than did W256 cells in the bones of non-Leydig tumor-bearing rats. The TdRs of W256 cells in the liver, lungs, and kidneys were not affected by Leydig tumor burden. In this model, enhanced bone resorption was associated with the selective growth promotion of metastatic W256 cells in bone, suggesting the existence of a bone-derived factor which is mitogenic to W256 cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulation of bone resorption was shown to specifically increase the proliferation rate of metastatic cancer cells in bone, but not in other tissues (303).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [303]
Citations
Cites
A METHOD FOR THE RAPID DETERMINATION OF ALKALINE PHOSPHATASE WITH FIVE CUBIC MILLIMETERS OF SERUM
Bessey, O. A., Lowry, O. H., & Brock, M. J. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43072-4 · Cited by 3,046
NEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.
Robey, P. G., Young, M. F., Flanders, K. C., Roche, N. S., Kondaiah, P., Reddi, A. H., Termine, J. D., Sporn, M. B., & Roberts, A. B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.1.457 · Cited by 557 · cited 1×
“TGF-fl is a component of organic bone matrix [30], and is synthesized and secreted by osteoblasts [ 31 ].”
BackgroundNicolson, G. L. (1988) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00046483 · Cited by 502 · cited 1×
“Human malignancies often have distinct, predictable patterns of hematogenous spread which are independent of the first capillary bed encountered [ 4 ].”
BackgroundPowell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 445
Use of P-Nitrophenylphosphate as the Substrate in Determination of Serum Acid Phosphatase*
Andersch, M. A., & Szczypinski, A. J. (1947) · American Journal of Clinical Pathology · doi:10.1093/ajcp/17.7_ts.571 · Cited by 318
Yates, A. J., Gutierrez, G. E., Smolens, P., Travis, P. S., Katz, M. S., Aufdemorte, T. B., Boyce, B. F., Hymer, T. K., Poser, J. W., & Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113406 · Cited by 268 · cited 1×
“These effects on the skeleton have recently been attributed to the production and secretion by Leydig tumor cells of parathyroid hormone-related protein (PTHrP) [20, 21], a polypeptide which has been shown to cause similar systemic skeletal responses when directly injected into rats [ 22 , 23].”
BackgroundTechniques in Cell Cycle Analysis
(1987) · Humana Press eBooks · doi:10.1007/978-1-60327-406-7 · Cited by 159
Nicolson, G. L., & Dulski, K. M. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380221 · Cited by 143 · cited 1×
“been shown to be influenced by the environment within the tissues that they colonize [ 1-3 ].”
BackgroundFinkelman, R. D., Linkhart, T. A., Mohan, S., Lau, K. H., Baylink, D. J., & Bell, N. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3657 · Cited by 105 · cited 1×
“TGF-fl is a component of organic bone matrix [ 30 ], and is synthesized and secreted by osteoblasts [31].”
Background
Research works printed but not linked: 1
- Easty GC and Carter RL. Patterns and mechanisms of bone destruction by skeletal metastases. In: Symington T and Carter RL, eds. Oncology Supplement: Scientific Foundation of Oncology. London: William Heinemann Medical Books, 1980.
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Self-citationBisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., & Papapoulos, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118841 · Cited by 305
Morony, S., Capparelli, C., Sarosi, I., Lacey, D. L., Dunstan, C. R., & Kostenuik, P. J. (2001) · PubMed · Cited by 318
Self-citationZoledronic Acid Inhibits Visceral Metastases in the 4T1/luc Mouse Breast Cancer Model
Hiraga, T., Williams, P. J., Ueda, A., Tamura, D., & Yoneda, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0325 · Cited by 242
Hiraga, T., Williams, P. J., Mundy, G. R., & Yoneda, T. (2001) · PubMed · Cited by 256
Mehta, P. B., Jenkins, B. L., McCarthy, L., Thilak, L., Robson, C. N., Neal, D. E., & Leung, H. Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206154 · Cited by 179
“The pathophysiology of bone metastases in prostate cancer is poorly understood, although in other tumour types accumulating evidence suggests that osteotropism may be related to an ability to activate osteoclasts and stimulate bone resorption (Kostenuik et al., 1992; Thomas et al., 1999).”
BackgroundOsteotropic cancers: From primary tumor to bone
Buijs, J. T., & van der Pluijm, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.044 · Cited by 167
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
Muir, J., Andrew, M., Hirsh, J., Weitz, J., Young, E., Deschamps, P., & Shaughnessy, S. (1996) · Blood · doi:10.1182/blood.v88.4.1314.bloodjournal8841314 · Cited by 153
van der Pluijm, G., Sijmons, B., Vloedgraven, H. J., Deckers, M. M. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1077 · Cited by 124
van der Pluijm, G., Que, I., Sijmons, B., Buijs, J. T., Löwik, C. W. G. M., Wetterwald, A., Thalmann, G. N., Papapoulos, S. E., & Cecchini, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4188 · Cited by 128
Hirbe, A. C., Uluçkan, Ö., Morgan, E. A., Eagleton, M. C., Prior, J. L., Piwnica-Worms, D. R., Trinkaus, K. M., Apicelli, A. J., & Weilbaecher, K. N. (2006) · Blood · doi:10.1182/blood-2006-09-048686 · Cited by 99
Hiraga, T., Myoui, A., Choi, M. E., Yoshikawa, H., & Yoneda, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2012 · Cited by 89
“Accumulating evidence suggests that these bone-derived growth factors modulate the metabolic activity of cancer cells metastasized in bone (20, 22, 26, 27).”
BackgroundUse of bisphosphonates in cancer patients
Body, J., Coleman, R. E., & Piccart, M. J. (1996) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(96)90020-1 · Cited by 89
Biochemical markers and skeletal metastases
Demers, L. M., Costa, L., & Lipton, A. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2919::aid-cncr7>3.0.co;2-z · Cited by 161
Self-citationBlouin, S., Baslé, M. F., & Chappard, D. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9002-5 · Cited by 64
van der Pluijm, G., Löwik, C. W. G. M., & Papapoulos, S. E. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0143 · Cited by 63
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone
Hirbe, A. C., Rubin, J., Uluçkan, Ö., Morgan, E. A., Eagleton, M. C., Prior, J. L., Piwnica-Worms, D. R., & Weilbaecher, K. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705203104 · Cited by 56
Kostenuik, P. J., Singh, G., & Orr, F. W. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018484323210 · Cited by 52
Self-citationMechanisms involved in the metastasis of cancer to bone
Orr, F. W., Kostenuik, P. J., Sanchez-Sweatman, O. H., & Singh, G. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00662140 · Cited by 41
Self-citationInhibition of bone resorption and growth of breast cancer in the bone microenvironment
Buijs, J. T., Que, I., Löwik, C. W. G. M., Papapoulos, S. E., & van der Pluijm, G. (2008) · Bone · doi:10.1016/j.bone.2008.10.047 · Cited by 45
“Animal and human studies have shown that high bone remodeling promotes the formation of bone metastases [8–10,13] through the release of factors from bone matrix that support metastatic growth in the bone marrow [1,26].”
BackgroundBone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells
Okada, T., Akikusa, S., Okuno, H., & Kodaka, M. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1027362507683 · Cited by 40
“Accumulating evidences suggests that bone marrow metastatic activity of certain tumors may be related to their ability to activate osteoclasts and stimulate bone resorption [ 22 , 23].”
BackgroundKessler, B. E., Sharma, V., Zhou, Q., Jing, X., Pike, L. A., Kerege, A. A., Sams, S. B., & Schweppe, R. E. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0007 · Cited by 33
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications
Terpos, E., & Dimopoulos, M. A. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0974-x · Cited by 32
“Furthermore, in an animal model wherein bone resorption was stimulated by tumor cells, the proliferation rate of metastatic cancer cells was increased in bone but not in other tissues [55].”
BackgroundCauses and Treatment of Bone Pain of Malignant Origin
Thurlimann, B. J. K., & de Stoutz, N. (1996) · Drugs · doi:10.2165/00003495-199651030-00004 · Cited by 31
Nannuru, K. C., Futakuchi, M., Sadanandam, A., Wilson, T. J., Varney, M. L., Myers, K. J., Li, X., Marcusson, E. G., & Singh, R. K. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9279-2 · Cited by 18
Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis
Akoury, E., Luna, A. S. R. G., Ahangar, P., Gao, X., Zolotarov, P., Weber, M. H., & Rosenzweig, D. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081212 · Cited by 14
Schem, C., Bauerschlag, D., Bender, S. T., Lorenzen, A.-C., Loermann, D., Hamann, S., Rösel, F., Kalthoff, H., Glüer, C., Jonat, W., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-32 · Cited by 15
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or A number of preclinical studies have demonstrated that heightened bone resorption creates an environment that promotes growth of breast and prostate cancer cells [2-7].”
BackgroundNicolin, V., & Narducci, P. (2008) · Acta Histochemica · doi:10.1016/j.acthis.2008.09.011 · Cited by 10
Löwik, C. W. G. M., Cecchini, M. G., Maggi, A. C., & van der Pluijm, G. (2006) · Springer eBooks · doi:10.1007/3-540-26809-x_11 · Cited by 5
The Light and Dark Side of Bisphosphonates
Jimi, E., Takami, M., Hiraga, T., Nakamura, I., Urade, M., & Miyamoto, Y. (2009) · Journal of Oral Biosciences · doi:10.1016/s1349-0079(09)80001-7 · Cited by 4
Low-dose prednisone and increased risk of development of bone metastases
Body, J. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010685 · Cited by 1
Mécanismes impliqués dans l’invasion de l’os par les cellules tumorales
van der Pluijm, G. (2002) · Revue du Rhumatisme · doi:10.1016/s1169-8330(02)00430-1 · Cited by 1
OPG, RANK and RANKL in Bone Metastasis and Cancer-Associated Osteolysis
Kostenuik, P. J. (2004) · Cancer metastasis · doi:10.1007/978-1-4020-2036-0_11 · Cited by 1
Self-citationOsteoimmunology and Cancer - Clinical Implications
Terpos, E., Gkotzamanidou, M. A., Christoulas, D., & Meletios, A. (2011) · InTech eBooks · doi:10.5772/23546
“Furthermore, in an animal model wherein bone resorption was stimulated by tumor cells, the proliferation rate of metastatic cancer cells was increased in bone but not in other tissues [55].”
Background
Metadata
- Authors
- Kostenuik, P. J., Singh, G., Suyama, K. L., & Orr, F. W.
- Affiliations
- McMaster University (CA)
- Venue
- Clinical & Experimental Metastasis
- Published
- 1992-11
- Volume
- 10
- Issue
- 6
- Pages
- 411-418
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W2048584238
- Cited by
- 34
- References
- 37
- Citations by year
- 2019: 1 · 2016: 1 · 2013: 1
- FWCI
- 0.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Surgery › Management of metastatic bone disease
- Keywords
- bone metastasis, bone resorption, bone remodeling, Walker 256 carcinosarcoma, osteoclasts, osteoblasts, trabecular bone, tumor cell proliferation, bone morphometry, serum calcium
- MeSH terms
- Animals, Body Burden, Bone Neoplasms, Bone Resorption, Calcium, Carcinoma 256, Walker, Cell Division, Leydig Cell Tumor, Male, Neoplasm Transplantation, Pilot Projects, Rats, Inbred F344, Testicular Neoplasms, Thymidine, Tritium, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.